By Nigam Arora & Dr. Natasha Arora
NHI is a medical REIT. The lease from its largest tenant is under market and coming due for renewal in 2026. Assuming, that the lease is negotiated at market rate, NHI stock can go up.
There is also an activist investor in this stock.
Keep in mind NHI is an REIT. REITs move slow. They are not like tech stocks.
Dividend
NHI pays a dividend of 5.17%.
Zones
For those following the Good Way, the Buy Now rating is *** (To see the locked content, please take a 30 day free trial) to start a small scale in.
For those following the Best Way, the buy zone is $*** – $*** to scale in.
The recommended quantity is *** of the full core position size.
The target zone is $81.68 – $84.34.
The mental stop zone is $*** – $***. Those who want a closer stop may consider a mental stop zone of $*** – $***. Please see the Trade Management Guidelines to learn about mental stop zones.
This is a medium to long term position.
If a new lease is negotiated at a higher rate and the stock moves up on the news, the plan will be to take advantage of the strength and sell the stock.
At The Arora Report, we use over 50 different strategies. This trade belongs to the strategy of getting ahead of the news.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
